2 days Rhythm Pharmaceuticals (NASDAQ:RYTM) Given New $52.00 Price Target at Bank of AmericaMarketBeat
Bank of America upped their target price on shares of Rhythm Pharmaceuticals from $48.00 to $52.00 and gave the stock a “neutral” rating in a research report on Monday.
Bank of America (BAC) · Nasdaq 100 · Pharmaceuticals · Science
X